Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates CBRL Q1 2026 Earnings Profitability Surprise as EPS Crushes Estimates CCCC Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid PreRevenue Phase YUMC Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower NerdWallet Q1 2026 Earnings EPS Beats Estimates by 108 Amid Strong Performance FINV Q4 2025 Earnings Earnings Per Share Reported at 1722925 Amid Market Headwinds